
Please try another search
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Name | Age | Since | Title |
---|---|---|---|
James J. Lalonde | 63 | 2024 | Independent Director |
Yi Tang | - | - | Member of Scientific Advisory Board |
Anthony DiGiandomenico | 58 | 2019 | Director |
Christopher A. Marlett | 60 | 2019 | Chairman |
Lon Edward Bell | 83 | 2024 | Independent Director |
Edgardo Rayo | - | 2025 | Director |
James U. Bowie | 63 | 2019 | Founder & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review